[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Barrera et al., 1995 - Google Patents

Effect of methotrexate alone or in combination with sulphasalazine on the production and circulating concentrations of cytokines and their antagonists. Longitudinal …

Barrera et al., 1995

View PDF
Document ID
6190791238237792995
Author
Barrera P
Haagsma C
BOERBOOMS A
van Riel P
Borm G
Van de Putte L
van der Meer J
Publication year
Publication venue
Rheumatology

External Links

Snippet

In a recent study from our group, the combination of methotrexate and sulphasalazine (MTX+ SASP) seemed superior to MTX alone in the treatment of rheumatoid arthritis (RA). To assess the impact of these therapies on the cytokine cascade, the in vitro production and …
Continue reading at repository.ubn.ru.nl (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution

Similar Documents

Publication Publication Date Title
Barrera et al. Effect of methotrexate alone or in combination with sulphasalazine on the production and circulating concentrations of cytokines and their antagonists. Longitudinal evaluation in patients with rheumatoid arthritis
Chomarat et al. Balance of IL-1 receptor antagonist/IL-1 beta in rheumatoid synovium and its regulation by IL-4 and IL-10.
Barrera et al. Circulating soluble tumor necrosis factor receptors, interleukin‐2 receptors, tumor necrosis factor α, and interleukin‐6 levels in rheumatoid arthritis.
Ahmed et al. Immunomodulatory effects of blood letting cupping therapy in patients with rheumatoid arthritis
Yanni et al. Synovial tissue macrophages and joint erosion in rheumatoid arthritis.
Bresnihan et al. Treatment of rheumatoid arthritis with recombinant human interleukin‐1 receptor antagonist
Constantin et al. Antiinflammatory and immunoregulatory action of methotrexate in the treatment of rheumatoid arthritis: Evidence of increased interleukin‐4 and interleukin‐10 gene expression demonstrated in vitro by competitive reverse transcriptase‐polymerase chain reaction
Lindberg et al. Inclusion body myositis: clinical, morphological, physiological and laboratory findings in 18 cases
Di Giovine et al. Tumour necrosis factor in synovial exudates.
Oka et al. Circulating interleukin 6 as a useful marker for predicting postoperative complications
Granowitz et al. Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans
Miossec et al. Inhibition of the production of proinflammatory cytokines and immunoglobulins by interleukin‐4 in an ex vivo model of rheumatoid synovitis
Boiardi et al. Relationship between serum RANTES levels and radiological progression in rheumatoid arthritis patients treated with methotrexate
US11406688B2 (en) Compositions and methods for the systemic treatment of arthritis
Lubberts et al. Regulatory role of interleukin 10 in joint inflammation and cartilage destruction in murine streptococcal cell wall (SCW) arthritis. More therapeutic benefit with IL-4/IL-10 combination therapy than with IL-10 treatment alone
Perkins et al. Reduction of NOS2 overexpression in rheumatoid arthritis patients treated with anti‐tumor necrosis factor α monoclonal antibody (cA2)
AR034049A1 (en) USE OF ANTI-TNF ANTIBODIES AS PHARMACES IN THE TREATMENT OF SEPTIC DISORDERS OF AEMIC PATIENTS
Webb et al. Osteoarthritic synovial fluid and synovium supernatants up-regulate tumor necrosis factor receptors on human articular chondrocytes
Barrera et al. Circulating concentrations and production of cytokines and soluble receptors in rheumatoid arthritis patients: effects of a single dose methotrexate
Woods et al. Low-level production of interleukin-13 in synovial fluid and tissue from patients with arthritis
Alstergren et al. Insufficient endogenous control of tumor necrosis factor-alpha contributes to temporomandibular joint pain and tissue destruction in rheumatoid arthritis.
Di Giovine et al. Absence of correlations between indices of systemic inflammation and synovial fluid interleukin 1 (alpha and beta) in rheumatic diseases
Shingu et al. INCREASED IL-1 RECEPTOR ANTAGONIST (IL-lra) PRODUCTION AND DECREASED IL-lβ/IL-lra RATIO IN MONONUCLEAR CELLS FROM RHEUMATOID ARTHRITIS PATIENTS
Leirisalo-Repo et al. Production of TNF by monocytes of patients with early rheumatoid arthritis is increased
Schürmann et al. Soluble lnterleukin-2 Receptor, lnterleukin-6 and Interleukin-1 β in Patients with Crohn’s Disease and Ulcerative Colitis: Preoperative Levels and Postoperative Changes of Serum Concentrations